Metagenomi Files 8-K
Ticker: MGX · Form: 8-K · Filed: Sep 3, 2024 · CIK: 1785279
| Field | Detail |
|---|---|
| Company | Metagenomi, Inc. (MGX) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Metagenomi filed an 8-K, check for updates.
AI Summary
Metagenomi, Inc. filed an 8-K on September 3, 2024, to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial statements within the provided text.
Why It Matters
This filing indicates that Metagenomi, Inc. has made a regulatory submission to the SEC, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural document without immediate disclosed financial or operational impacts.
Key Players & Entities
- Metagenomi, Inc. (company) — Registrant
- September 03, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-41949 (commission_file_number) — SEC File Number
- 81-3909017 (irs_number) — IRS Employer Identification No.
- 5959 Horton Street 7th Floor (address) — Principal Executive Offices
- Emeryville (city) — Principal Executive Offices City
- California (state) — Principal Executive Offices State
- 94608 (zip_code) — Principal Executive Offices Zip Code
- (510) 871-4880 (phone_number) — Registrant's Telephone Number
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items being reported, but the specific details of these events are not provided in the excerpt.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 03, 2024.
What is Metagenomi, Inc.'s principal executive office address?
Metagenomi, Inc.'s principal executive offices are located at 5959 Horton Street, 7th Floor, Emeryville, California, 94608.
What is Metagenomi, Inc.'s SEC file number?
Metagenomi, Inc.'s SEC file number is 001-41949.
What is the SIC code for Metagenomi, Inc.?
The Standard Industrial Classification (SIC) code for Metagenomi, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-09-03 16:09:00
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MGX Nasdaq Glob
Filing Documents
- mgx-20240903.htm (8-K) — 39KB
- mgx-ex99_1.htm (EX-99.1) — 24KB
- img133734535_0.jpg (GRAPHIC) — 109KB
- 0000950170-24-102805.txt ( ) — 336KB
- mgx-20240903.xsd (EX-101.SCH) — 26KB
- mgx-20240903_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On September 3, 2024 Metagenomi, Inc. (the "Company") announced data from an ongoing preclinical study designed to provide evidence supporting the potential durability and safety of the company's hemophilia A gene editing investigational therapy, MGX-001. The Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein .
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release Issued by Metagenomi, Inc. on September 3, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Metagenomi, Inc. Date: September 3, 2024 By: /s/ Brian C. Thomas Brian C. Thomas Chief Executive Officer